Inactivation of TSE agents: safety of blood and blood-derived products
Author:
- 1 February 2003
- journal article
- review article
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 10 (1) , 23-25
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Studies on the removal of a bovine spongiform encephalopathy‐derived agent by processes used in the manufacture of human immunoglobulinVox Sanguinis, 2002
- Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissuesThe Lancet, 2001
- Letters to the EditorJournal of Hospital Infection, 2000
- Inactivation of Transmissible Degenerative Encephalopathy Agents: A ReviewThe Veterinary Journal, 2000
- Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt‐Jakob disease in humansTransfusion, 1999
- Risk of transmission of Creutzfeldt-Jakob disease by transfusion of blood, plasma, and plasma derivativesJournal of Clinical Apheresis, 1999
- Pooled plasma derivatives and Creutzfeldt-Jakob diseaseThe Lancet, 1995
- Can Creutzfeldt-Jakob disease be transmitted by transfusion?Current Opinion in Hematology, 1995
- Decontamination studies with the agents of bovine spongiform encephalopathy and scrapieArchives of Virology, 1994
- Disinfection studies with two strains of mouse-passaged scrapie agentJournal of the Neurological Sciences, 1983